Skin surface biomarkers are associated with future development of atopic dermatitis in children with family history of allergic disease

T Sato, J Nikolovski, R Gould, I Lboukili… - Skin Research and …, 2023 - Wiley Online Library
Background Atopic dermatitis (AD) is a common childhood chronic inflammatory skin
disorder that can significantly impact quality of life and has been linked to the subsequent …

41991 Early skin surface biomarkers associated with risk susceptibility to atopic dermatitis in children with family history of allergic disease

R Insel, T Sato, J Nikolovski, R Gould, I Lboukili… - Journal of the American …, 2023 - jaad.org
Background: Atopic dermatitis (AD), a chronic inflammatory skin disorder with an onset
commonly occurring during childhood, can have a significant impact on the quality of life of …

Early skin inflammatory biomarker is predictive of development and persistence of atopic dermatitis in infants

GN Stamatas, T Sato, CN Chaoimh, T Oddos… - Journal of Allergy and …, 2024 - Elsevier
Background The Short-Term Topical Application for Prevention of Atopic Dermatitis (STOP
AD) study, a randomized, open-label trial evaluating the effect of short-term (from the first 4 …

Biomarker prediction of pediatric atopic dermatitis severity

MH Kaplan, S Engle, CY Chang… - The Journal of …, 2020 - journals.aai.org
Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects 25% of children and
1–3% of adults worldwide, and has increased 2-to 3-fold over the past several decades. The …

Stratum corneum lipid and cytokine biomarkers at age 2 months predict the future onset of atopic dermatitis

E Berdyshev, J Kim, BE Kim, E Goleva… - Journal of Allergy and …, 2023 - Elsevier
Background Atopic dermatitis (AD) commonly occurs in children and can progress into
severe phenotypes or atopic march, causing significant impairment in quality of life. It is …

Seromarkers in childhood atopic dermatitis

KLE Hon, TF Leung - Expert Review of Dermatology, 2010 - Taylor & Francis
Significant advances in our understanding of the pathogenesis of atopic dermatitis (AD)
have led to improvements in therapy. Nevertheless, assessment of the condition and …

[HTML][HTML] Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters

DS Bakker, M de Graaf, S Nierkens… - Journal of Allergy and …, 2022 - Elsevier
Background Increasing evidence shows that pediatric atopic dermatitis (AD) differs from
adult AD on a biologic level. Broad biomarker profiling across a wide range of ages of …

Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins

F Lauffer, V Baghin, M Standl, SP Stark, M Jargosch… - Allergy, 2021 - Wiley Online Library
Background Atopic dermatitis (AD) is the most common inflammatory skin disease in
children, with 30% of all those diagnosed developing chronic or relapsing disease by …

Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell‐related immunity and angiogenesis

MA McAleer, I Jakasa, G Hurault… - British journal of …, 2019 - academic.oup.com
Background Biomarkers of atopic dermatitis (AD) are largely lacking, especially in infant AD.
Those that have been examined to date have focused mostly on serum cytokines, with few …

Predicting the future: Early-life biomarkers of atopic dermatitis

E Goleva - Journal of Allergy and Clinical Immunology, 2023 - jacionline.org
Atopic dermatitis (AD) is a chronic, heterogenous, inflammatory skin disease that typically
starts in childhood and often persists into adulthood. 1 AD affects up to 20% of children …